Adherence to treatment in patients with juvenile myoclonic epilepsy: Correlation with quality of life and adverse effects of medication

Journal of Epilepsy and Clinical Neurophysiology

Volumn 15, Issue 4, 2009, Pages 192-196

  Martins, Heloise Helena ^a   Alonso, Neide Barreira ^a   Guilhoto, Laura Maria F Ferreira ^a   Guaranha, Mirian S Bittar ^a   Yacubian, Elza Márcia Targas ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adherence to treatment; Adverse effects of medication; Antiepileptic drugs; Juvenile myoclonic epilepsy; Quality of life

Indexed keywords

ANTICONVULSIVE AGENT;

ADOLESCENT; ADULT; ADVERSE OUTCOME; AGED; ANAMNESIS; ARTICLE; BRAZIL; CLINICAL ARTICLE; CLINICAL EVALUATION; ELECTROENCEPHALOGRAPHY; FEMALE; HEALTH SURVEY; HUMAN; JUVENILE MYOCLONUS EPILEPSY; MALE; MONOTHERAPY; MYOCLONUS EPILEPSY; PATIENT COMPLIANCE; PILOT STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RESTLESSNESS; SCORING SYSTEM; SELF REPORT; SOCIAL STATUS; SOMNOLENCE;

EID: 77951701963     PISSN: 16762649     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1676-26492009000400010     Document Type: Article

References (27)

1. Asadi-Pooya AA. Drug compliance of children and adolescents with epilepsy. Seizure 2005;14:393-395 (Pubitemid 41200491)
2. Buck D, Jacoby A, Baker GA, Chadwick DW. Factors influencing compliance with antiepileptic drug regimes. Seizure 1997;6:87-93. (Pubitemid 27220013)
3. Buelow JM, Smith MC. Medication management by the person with epilepsy: perception versus reality. Epilepsy Behav 2004;5: 401-406
4. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-399
5. Cramer J, Glassman M, Rienzi V. The relationship between poor medication compliance and seizures. Epilepsy Behav 2002;3:338-342
6. Cramer J, Roy A, Burrell A, Fairchild J, Fuldeore J, Ollendorf A, Wong K. Medication compliance and persistence: terminology and definitions. Val Health 2007;11(1):44-47
7. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989;261:3273-3277
8. Da Silva TI, Ciconelli R, Alonso NB, Azevedo AM, Westphal-Guitti AC, Pascalicchio TF, Marques CM, Caboclo LOSF, Cramer JA, Sakamoto AC, Yacubian EMT. Validity and reliability of the portuguese version of the quality of life in epilepsy inventory (QOLIE-31) for Brazil. Epilepsy Behav 2007;10:234-241
9. Devinsky O. Psychiatric comorbidity in patients with epilepsy: implications for diagnosis and treatment. Epilepsy Behav 2003;4(4): 2-10.
10. Eraker S A, Kirscht JP, Becker MH. Understanding and improving patient compliance. Ann Intern Med 1984;100(2):258-268
11. Fincke BG, Miller DR, Spiro A. The interaction of patient perception of overmedication with drug compliance and side effects. J Gen Intern Med 1998;13:182-185
12. Gilliam FG, Fessler AJ, Baker G, Vahle V, Carter J, Attarian H. Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial. Neurology 2004;62:23-27
13. Gomes MDM, Maia Filho HDS. Medication-taking behavior and drug self regulation in people with epilepsy. Arq Neuropsiquiatr 1998; 56:714-719
14. Green LW, Simons-Morton DG. Denial, delay, and disappointment: discovering and overcoming the causes of drug errors and missed appointments. In: Schmidt D, Leppik IE (eds). Compliance in epilepsy. New York, Elsevier Science Publishers BV (Biomedical Division); 1988:7-21.
15. Grudzinski AM, Hakim Z, Coons SJ, Labiner DM. Use of the QOLIE-31 in routine clinical practice. J Epilepsy 1998;11:34-47.
16. Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J. Can simple clinical measurements detect patient noncompliance? Hypertension 1980;2(6):757-764
17. Hovinga CA, Asato MR, Manjunath R, Wheless JW, Phelps SJ, Sheth RD, Pina-Garza JE, Zingaro WM, Haskins LS. Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: survey of patients with epilepsy and physicians. Epilepsy Behav 2008;13:316-322
18. Janz D, Christian W. Impulsiv petit mal. Dtsch Z Nervenheilk 1957; 176:346-386
19. Janz D, Christian W. Impulsive petit mal. In: Malafosse A, Genton P, Hirsch C, Marescaux C, Broglin D, Bernasconi R (eds). Idiopathic generalized epilepsies: clinical, experimental and genetic aspects. London, John Libbey;1994:229-251
20. Jones RM, Butler JA, Thomas VA, Peveler RC, Prevett M. Adherence to treatment in patients with epilepsy: associations with seizure control and illness beliefs. Seizure 2006;15:504-508
21. Leppik IE. How to get patients with epilepsy to take their medication: the problem of noncompliance. Postgrad Med 1990;88: 253-256
22. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24(1):67-74.
23. O'Brien MK, Petrie K, Raeburn J. Compliance to medication regimens: updating a complex medical issue. Med Care 1992;49: 435-454
24. Paschal AM, Hawley SR, Romain TS, Ablah E. Measures of adherence to epilepsy treatment: review of present practices and recommendations for future directions. Epilepsia 2008;49(7):1115-1122
25. Schmitz B. Depressive disorders in epilepsy. In: Trimble MR, Schmitz B (eds). Seizures, affective disorders and anticonvulsant drugs. Guildford: Clarius; 2002. p. 19-30.
26. Stanaway L, Lambie DG, Johnson RH. Non-compliance with anticonvulsant therapy as a cause of seizures. N Z Med J 1985; 98(774):150-152
27. Yeager KA, Dilorio C, Shafer O, McCarty F, Letz R, Henry T, Schomer DL. The complexity of treatments for persons with epilepsy. Epilepsy Behav 2005;7:679-686